PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
PSTX
Delisted
PSTX was delisted on the 7th of January, 2025.
62 hedge funds and large institutions have $276M invested in Poseida Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
62
Holders Change
+6
Holders Change %
+10.71%
% of All Funds
1.09%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
26
Reduced
9
Closed
10
Calls
$131K
Puts
–
Net Calls
+$131K
Net Calls Change
+$133K
Top Buyers
| 1 |
BlackRock
New York
|
$27M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
$13.7M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
$3.97M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$3.68M |
| 5 |
JPMorgan Chase & Co
New York
|
$2.97M |
